Proposed Schema for First-Line Therapy of Metastatic Urothelial Carcinoma*

dailynews.ascopubs.org/do/selecting-f…

Guru P. Sonpavde, MD #Cancer #Oncology #meded #MedX

*All of these trials required satisfactory organ function and controlled comorbidities, including DM.

Algorithm of Colon cancer

Oncology Brothers #OncoDaily #oncology #meded #MedX

Adjuvant Alectinib in ALK-Rearranged NSCLC — Here and Now

#NSCLC #Oncology #MedEd #medx
nejm.org/doi/full/10.10…

⭐️Can AI help in early detection of pancreatic cancer? In this perspective my great friend & the amazing Anirban Maitra & the terrific Eric Topol team up to show that AI has an enormous potential in early detection in this deadly disease. Right in time just after the AACR meeting…

Alectinib in Resected ALK-Positive Non–Small-Cell Lung Cancer

NEJM #Oncology #NSCLC #MedEd #medx

nejm.org/doi/full/10.10…

In this review, authors provide a brief historical account of micronuclei, depict the mechanisms underpinning their creation, and illuminate their capacity to propel tumor evolution through genetic, epigenetic, and transcriptional transformations #AACR24

aacrjournals.org/cancerdiscover…

If you're attending the #AACR24 session on Genomic Instability and Metastasis, don't miss recent work in Cancer Discovery by session speaker Turajlic Lab @ The Crick doi.org/10.1158/2159-8… The Crick

🎯kmplot.com

Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors.

The Innovation | Medicine The Innovation: a Cell Press partner journal #AACR24 @OncoDaily AACR #CancerResearch #Oncology #bioinformatics

cell.com/the-innovation…

Poster section 35, board #8.

Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors

AACR #AACR24

cell.com/the-innovation…

Have you ever use kmplot.com in your research?

🎯Now it's updated. You can cite this new paper (just online).

🎯Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. #AACR24

cell.com/the-innovation…

📍Today is the day ‼️
📍Honored & thrilled to Chair the Plenary session at AACR #AACR24
✅Plenary: AI at the Interface: Accelerating Evidence Generation, Advancing Disparities Research, & Improving Trial Design
✅If you're at #AACR24 , don't miss it.
👉A rockstar panel of…

The pan-RAF-MEK non degrading molecular glue NST-628 is a potent and brain penetrant inhibitor of the RAS-MAPK pathway with activity across diverse RAS- and RAF-driven cancers

Cancer Discovery OncoAlert OncoDaily #oncology #AACR24 Tali Lev Elizabeth McKenna

aacrjournals.org/cancerdiscover…

Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer

Cancer Discovery Oncology Brothers OncoAlert OncoDaily AACR President Patricia M. LoRusso Clinical Cancer Research #oncology #Cancer #meded #MedX #AACR24 #AACR2024 Tali Lev Elizabeth McKenna

aacrjournals.org/cancerdiscover…

ZNF397 Deficiency Triggers TET2-driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate Cancer

Cancer Discovery Oncology Brothers OncoAlert OncoDaily AACR President Patricia M. LoRusso Clinical Cancer Research #oncology #Cancer #meded #MedX #AACR24 #AACR2024 Tali Lev Elizabeth McKenna

aacrjournals.org/cancerdiscover…

St. Jude Survivorship Portal: sharing and analyzing large clinical and genomic datasets from pediatric cancer survivors

Cancer Discovery Oncology Brothers OncoAlert OncoDaily AACR President Patricia M. LoRusso Clinical Cancer Research #oncology #Cancer #meded #MedX #AACR24 Tali Lev Elizabeth McKenna

aacrjournals.org/cancerdiscover…

Thank you to the IU Graduate School Bloomington Medical Molecular Genetics program for the invitation to speak at the seminar series on The Shields Lab research - Misty Dawn Shields

#Cancer #SchoolOfMedicine #LungCancer #OncoDaily #Oncology #SCLC

oncodaily.com/45030.html

Thanks to my colleagues for a productive discussion of ways to advance the goals of the National Cancer Plan. The opportunities for progress are enormous, but we must convince Congress to invest in those opportunities by continuing robust funding for NIH and NCI.